Javascript must be enabled to continue!
Growth inhibition of Akkermansia muciniphila by a secreted pathobiont sialidase
View through CrossRef
AbstractAkkermansia muciniphila is considered a key constituent of a healthy gut microbiota. In inflammatory bowel disease (IBD), A. muciniphila has a reduced abundance while other, putative pathogenic, mucus colonizers bloom. We hypothesized that interbacterial competition may contribute to this observation. By screening the supernatants of a panel of enteric bacteria, we discovered that a previously uncharacterized Allobaculum species potently inhibits the growth of A. muciniphila. Mass spectrometry analysis identified a secreted Allobaculum sialidase as inhibitor of A. muciniphila growth. The sialidase targets sialic acids on casein O-glycans, thereby altering the accessibility of nutrients critical for A. muciniphila. The altered glycometabolic niche results in distorted A. muciniphila cell division and efficiently arrests its growth. The identification of a novel mechanism of A. muciniphila growth inhibition by a competing bacterial pathobiont may provide a rationale for interventions aimed at restoring and maintaining a healthy microbiota symbiosis in patients with intestinal disease.
Cold Spring Harbor Laboratory
Title: Growth inhibition of Akkermansia muciniphila by a secreted pathobiont sialidase
Description:
AbstractAkkermansia muciniphila is considered a key constituent of a healthy gut microbiota.
In inflammatory bowel disease (IBD), A.
muciniphila has a reduced abundance while other, putative pathogenic, mucus colonizers bloom.
We hypothesized that interbacterial competition may contribute to this observation.
By screening the supernatants of a panel of enteric bacteria, we discovered that a previously uncharacterized Allobaculum species potently inhibits the growth of A.
muciniphila.
Mass spectrometry analysis identified a secreted Allobaculum sialidase as inhibitor of A.
muciniphila growth.
The sialidase targets sialic acids on casein O-glycans, thereby altering the accessibility of nutrients critical for A.
muciniphila.
The altered glycometabolic niche results in distorted A.
muciniphila cell division and efficiently arrests its growth.
The identification of a novel mechanism of A.
muciniphila growth inhibition by a competing bacterial pathobiont may provide a rationale for interventions aimed at restoring and maintaining a healthy microbiota symbiosis in patients with intestinal disease.
Related Results
Akkermansia muciniphila: A next-generation gut probiotic supporting neurorepair and functional recovery
Akkermansia muciniphila: A next-generation gut probiotic supporting neurorepair and functional recovery
Abstract
The brain–gut axis is a bidirectional signal transduction system between the gastrointestinal tract and the central nervous system that integrates neural, endocr...
Ureaplasma parvum infection induces inflammatory changes in vaginal epithelial cells independent of sialidase
Ureaplasma parvum infection induces inflammatory changes in vaginal epithelial cells independent of sialidase
Abstract
Background
Ureaplasma, a subspecies of genital Mycoplasma is one of the most common microbes isolated from women with infection/inflammation-associated preterm l...
Akkermansia muciniphila, a bacteria against obesity and its relationship with diet. Systematic review
Akkermansia muciniphila, a bacteria against obesity and its relationship with diet. Systematic review
The anaerobic bacterium Akkermansia muciniphila has demonstrated its role in regulating metabolism and markers of inflammation since its discovery. It is a Gram-negative bacteria t...
Preliminary Evaluation of the Safety and Probiotic Potential of Akkermansia muciniphila DSM 22959 in Comparison with Lactobacillus rhamnosus GG
Preliminary Evaluation of the Safety and Probiotic Potential of Akkermansia muciniphila DSM 22959 in Comparison with Lactobacillus rhamnosus GG
In this study, for the first time, we examined some of the physico-chemical properties of the cell surface of Akkermansia muciniphila DSM 22959, comparing it with those of Lactobac...
Abstract IA010: Engineering human sialidase as novel cancer therapeutics by targeting sialoglycans
Abstract IA010: Engineering human sialidase as novel cancer therapeutics by targeting sialoglycans
Abstract
Immune checkpoint blockade has revolutionized cancer treatment, but resistance remains a significant hurdle for many patients. Sialoglycans, as new immune c...
An Ifnar1 allele impairs the colonization of gut bacteria
and promotes tuberculosis
An Ifnar1 allele impairs the colonization of gut bacteria
and promotes tuberculosis
Abstract
Both host genetics and gut microbiome have important effects on human health, yet how host genetics regulates gut bacteria and further determines disease susceptib...
Alterations of gut bacteria Akkermansia muciniphila and Faecalibacterium prausnitzii in late post-transplant period after liver transplantation
Alterations of gut bacteria Akkermansia muciniphila and Faecalibacterium prausnitzii in late post-transplant period after liver transplantation
Introduction: Recent studies have shown that the intestinal microbiota can modulate certain systemic metabolic and immune responses, including liver graft function and the developm...
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract
Considering that a tumor promoting role for GSK3 has been suggested in pancreatic cancer (PC) cells and that GSK3 inhibitors are currently under clinical tr...

